#ASCO20 top 3 according to Brad:
$JNJ's BCMA CART data
$ROG Roche's TIGIT data on top of PD-L1
$AZN AstraZeneca Tagrisso data in EGFR lung cancer and Enhertu data in non-breast cancer HER2 positive tumors. https://t.co/F9SlM6cG8l